+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ex vivo expansion of megakaryocyte progenitors from human umbilical cord blood CD34(+) cells



Ex vivo expansion of megakaryocyte progenitors from human umbilical cord blood CD34(+) cells



Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(5): 1121-1125



This study was purposed to investigate the biological characteristics and immunogenicity changes of ex vivo expanded megakaryocyte progenitors from human umbilical cord blood CD34(+) cells in order to provide experimental basis for clinical application of ex vivo expanded umbilical cord blood megakaryocyte progenitor cells. Mononuclear cells (MNCs) were obtained from umbilical cord blood by Ficoll-Hyapaque density gradient separation. CD34(+) cells were enriched by magnetic cell sorting (MACS). The selected CD34(+) cells were seeded in serum-free medium stimulated with thrombopoietin (TPO, 50 ng/ml), interleukin 11 (IL-11, 50 ng/ml), and heparin (25 U/ml) for 14 days. The immunophenotyping (CD34(+), CD41a(+), CD61(+), CD34(+) CD41a(+) and CD34(+) CD61(+) cells) of amplificated products, matured megakaryocyte apoptosis, and expression of human leukocyte antigen (HLA) class I and class II molecules were measured by fluorescence-activated cell sorter (FACS). The number of colony-forming units-megakaryocyte (CFU-Mk) was also evaluated by CFU-Mk assay. The results showed that the umbilical cord blood CD34(+) mononuclear cells could be effectively differentiated into megakaryocytes. The peak expression ratios of CD41a(+) and CD61(+) cells were all at 14th days, while that of CD34(+) CD41(+) and CD34(+) CD61(+) cells were at 7th day [(3.41 +/- 2.80)% and (1.89 +/- 1.43)%, respectively]. The expansion times of large and small CFU-Mk reached peak at 7th day (20.66 +/- 32.79) and 10th day (435.62 +/- 482.65), respectively. The apoptotic rates of megakaryocytes at 7th, 10th, 14th day were (19.48 +/- 9.64)%, (26.87 +/- 9.03)%, and (52.46 +/- 11.74)%, respectively. The apoptotic rate of megakaryocytes had no significant difference in 7 and 10 days culture (p > 0.05), while that significantly increased in culture for 14 day culture, compared with culture for 7 and 10 days (p < 0.05, respectively). The expression of HLA class I and class II molecules on megakaryocytes decreased along with the prolongation of expansion time and sharply decreased in 0 to 10 days. It is concluded that the cytokines of TPO, IL-11, and heparin can promote the expansion of megakaryocyte progenitors from umbilical cord blood CD34(+) mononuclear cells effectively in vitro. The peaked expansion times of large CFU-Mk, the peaked expression ratios of CD34(+) CD41(+) and CD34(+) CD61(+) cells were all at 7th day. So the culture for 7 days appeared to be the optimal duration of expanding megakaryocyte progenitors.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 053107944

Download citation: RISBibTeXText

PMID: 18928609


Related references

Ex vivo expansion of umbilical cord blood cells generated from CD34+ progenitors by using a megakaryocyte-active cytokine combination. Infusion Therapy & Transfusion Medicine 28(6): 318-325, 2001

Ex vivo Expansion of Umbilical Cord Blood Cells Generated from CD34+ Progenitors by Using a Megakaryocyte-Active Cytokine Combination. Transfusion Medicine and HemoTherapy 28(6): 318-325, 2001

Human mesenchymal stem cells enhance ex vivo expansion of human megakaryocyte, erythroid and myeloid progenitors from purified cord blood CD34+ cells. Blood 92(10 Suppl. 1 Part 1-2): 725A, 1998

Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(6): 1398-1402, 2008

Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34+ cells in a closed system. Pediatric Research 51(4 Part 2): 245A, 2002

Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biology of Blood and Marrow Transplantation 9(3): 151-156, 2003

Preclinical ex-vivo expansion of human megakaryocyte progenitors from umbilical cord blood for transplantation using a new two-step separation procedure. Blood 92(10 Suppl. 1 Part 1-2): 310B, 1998

Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood: A potential source of megakaryocytes for transplantation. Experimental Hematology (Charlottesville) 30(9): 1079-1087, 2002

In Vitro Differentiation and Expansion of Intrathymic T Cell Progenitors from Human Umbilical Cord Blood-Derived CD34(+) Cells. International Journal of Stem Cells 2(1): 45-50, 2009

Optimizing megakaryocyte precursor expansion of umbilical cord blood CD34+ cells. Blood 94(10 Suppl. 1 Part 2): 350b, 1999

Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure. British Journal of Haematology 103(3): 639-650, 1998

Ex vivo expansion of cord blood CD34+ cells on human cord vein endothelial cells derived from a single umbilical cord. Experimental Hematology (Charlottesville) 30(6 Suppl. 1): 44, 2002

Ex vivo expansion of CD34+ cells from human umbilical cord blood. Blood 88(10 Suppl. 1 Part 1-2): 603A, 1996

Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(3): 645-649, 2008

Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture. CytoTherapy 13(4): 467-480, 2011